MARKET

SIBN

SIBN

Si-Bone
NASDAQ
11.61
-0.66
-5.38%
After Hours: 13.04 +1.43 +12.29% 19:58 05/11 EDT
OPEN
12.37
PREV CLOSE
12.27
HIGH
12.37
LOW
11.48
VOLUME
1.75M
TURNOVER
--
52 WEEK HIGH
21.89
52 WEEK LOW
11.48
MARKET CAP
513.67M
P/E (TTM)
-26.3864
1D
5D
1M
3M
1Y
5Y
1D
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
Reuters · 3h ago
SI-BONE Posts Double-Digit Q1 Growth, Raises 2026 Guidance; Stock Up
NASDAQ · 5h ago
SI-BONE INC <SIBN.O>: JEFFERIES CUTS TARGET PRICE TO $23 FROM $28
Reuters · 6h ago
Analysts Offer Insights on Healthcare Companies: SI-Bone (SIBN) and MoonLake Immunotherapeutics (MLTX)
TipRanks · 9h ago
Closing Bell Movers: Hims & Hers down 12% on earnings miss
TipRanks · 11h ago
SI-BONE raises 2026 revenue outlook to $230 million-$233 million
PUBT · 14h ago
SI-BONE GAAP EPS of -$0.10 beats by $0.09, revenue of $52.59M beats by $1.43M
Seeking Alpha · 14h ago
SI-Bone reports Q1 EPS (10c), consensus (19c)
TipRanks · 14h ago
More
About SIBN
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Webull offers SI-Bone Inc stock information, including NASDAQ: SIBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIBN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIBN stock methods without spending real money on the virtual paper trading platform.